EV has received research grants from AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Co., GlaxoSmithKline, Janssen-Cilag, Novartis, and Pfizer; is a speaker or is involved in advisory boards for AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Co., GlaxoSmithKline, Janssen-Cilag, Organon, Pfizer, Sanofi, and Servier; and is a consultant to AstraZeneca, Bial, Bristol-Myers Squibb, Eli Lily & Co., Janssen-Cilag, Lundbeck, Merck Sharp & Dohme, Novartis, Organon, Pfizer, Sanofi, Servier, and UCB. JRC has received research grants from Abbott, AstraZeneca, The Cleveland Foundation, GlaxoSmithKline, Janssen, NARSAD, Eli Lilly & Co., Repligen and The Stanley Medical Research Institute, and federal funding from the Department of Defense, Health Resources Services Administration and NIMH; and is a consultant or is involved in advisory boards for Abbott, AstraZeneca, Bristol-Myers Squibb, France Foundation, GlaxoSmithKline, Janssen, Johnson & Johnson Pharmaceutical Research & Development, and Solvay/Wyeth. JMG has received research grants from AstraZeneca and GlaxoSmithKline and is a consultant to Merck Sharp & Dohme. SR is an employee of AstraZeneca Pharmaceuticals LP. WM is a former employee of AstraZeneca Pharmaceuticals LP.

Publication History

Issue published online: 1 JUN 2007

Article first published online: 1 JUN 2007

Received 22 December 2005, revised and accepted for publication 8 January 2007